C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2694587
The present invention provides a biomarker (RAPGEF5) that is predictive for the response to treatment with an EGFR inhibitor in cancer patients.
La présente invention porte sur un biomarqueur (RAPGRF5) prédictif de la réponse à un traitement par inhibiteur d'EGFR chez des patients atteints d'un cancer.
Delmar Paul
Klughammer Barbara
Lutz Verena
Mcloughlin Patricia
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Predictive marker for egfr inhibitor treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Predictive marker for egfr inhibitor treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predictive marker for egfr inhibitor treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1539052